Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation (AVRO)

This study has been completed.
Information provided by:
Cardiome Pharma Identifier:
First received: April 25, 2008
Last updated: December 12, 2009
Last verified: December 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):